Nuloc 40 mg/vial (IV Injection)
40 mg vial: ৳ 90.00
Medicine Details
Category | Details |
---|---|
Generic | Esomeprazole |
Company | Monicopharma ltd |
Also available as |
Indications
- Relief from chronic heartburn symptoms
- Healing of erosive esophagitis
- Maintenance of healing of erosive esophagitis
- Eradication of Helicobacter pylori infection in patients with duodenal ulcer disease
- Treatment of Zollinger-Ellison Syndrome
- Treatment of Acid-related Dyspepsia
- Treatment of Duodenal and Gastric ulcer
Pharmacology
- Proton pump inhibitor
- Suppresses gastric acid secretion
- Specific inhibition of the H+/K+-ATPase in the gastric parietal cell
- Enteric-coated pellet formulation
- Metabolized in the liver
- Systemic bioavailability of approximately 90%
- Plasma elimination half-life of approximately 1–1.5 hours
Dosage
- Oral dosage form
- 20 mg or 40 mg Once Daily for 4-8 Weeks for healing of erosive esophagitis
- 20 mg Once Daily for maintenance of healing of erosive esophagitis
- 20 mg Once Daily for symptomatic GERD
- Triple Therapy for Helicobacter pylori eradication
- 20-80 mg once daily for Zollinger-Ellison Syndrome
- 20-40 mg once daily for acid-related Dyspepsia
- 20 mg once daily for 2-4 weeks for Duodenal ulcer
- 20-40 mg once daily for 4-8 weeks for Gastric ulcer
- IV Injection for GERD with Erosive Esophagitis in adult and pediatric patients
- IV Infusion for risk reduction of rebleeding of Gastric or Duodenal Ulcers in adult patients
Administration
- Tablet or capsule should be swallowed whole and taken one hour before a meal
- Oral Suspension should be taken with water and administered through a nasogastric or gastric tube if needed
- IV Injection should be prepared with Sodium Chloride and administered intravenously over a period of at least 3 minutes
Interaction
- Extensively metabolized in the liver by CYP2C19 and CYP3A4
- No clinically relevant interactions with drugs metabolized by CYPs 1A2, 2A6, 2C9, 2D6, 2E1, and 3A4
- Potential interference with CYP2C19
- May interfere with the absorption of certain drugs
Contraindications
- Known hypersensitivity to any of the formulation
Side Effects
- Headache
- Diarrhea
- Nausea
- Flatulence
- Abdominal pain
- Constipation
- Dry mouth
Pregnancy & Lactation
- No adequate and well-controlled studies in pregnant women
- No teratogenic effects observed in animal studies
- Excretion in milk not studied
- Breastfeeding should be discontinued if essential
Precautions & Warnings
- Symptomatic response to therapy does not preclude the presence of gastric malignancy
- Instructions for patients on capsule intake and use of antacids
Use in Special Populations
- Safety and effectiveness in pediatric patients not established
- No overall differences in safety and efficacy observed between elderly and younger individuals
- No dosage adjustment recommended for patients with mild to moderate hepatic insufficiency
- No alteration expected in patients with renal impairment
Overdose Effects
- Lethal to rats at high doses
- Reduced motor activity
- Changes in respiratory frequency
- Tremor, ataxia, and intermittent clonic convulsions
Storage Conditions
- Store at a temperature not exceeding 30°C
- Dry place
- Protect from light and moisture
- Keep out of reach of children
Chemical Structure
- Molecular Formula: C17H19N3O3S
Common Questions about Nuloc 40 mg/vial Injection
- PPI for reducing stomach acid production
- Used for treating GERD, ulcers, and other conditions
- Common side effects include headaches, diarrhea, nausea, and others
- Considerations for pregnancy and breastfeeding
- Quick tips for taking the medication
Related Brands
- Esobest 40 mg/vial (IV Injection) - sharif-pharmaceuticals-ltd
- Esoral 20 mg (Oral Powder) - eskayef-pharmaceuticals-ltd
- Prazia 40 mg (Capsule (Enteric Coated)) - amico-laboratories-ltd
- Prazia 20 mg (Capsule (Enteric Coated)) - amico-laboratories-ltd
- Esover 40 mg (Capsule (Enteric Coated)) - veritas-pharmaceuticals-ltd